RENAU.UNSP.ARD 1/5 EO-20 (56S0) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.060x

Based on the latest financial reports, RENAU.UNSP.ARD 1/5 EO-20 (56S0) has a cash flow conversion efficiency ratio of 0.060x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€246.50 Million ≈ $288.18 Million USD) by net assets (€4.13 Billion ≈ $4.82 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

RENAU.UNSP.ARD 1/5 EO-20 - Cash Flow Conversion Efficiency Trend (2022–2025)

This chart illustrates how RENAU.UNSP.ARD 1/5 EO-20's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read debt load of RENAU.UNSP.ARD 1/5 EO-20 for a breakdown of total debt and financial obligations.

RENAU.UNSP.ARD 1/5 EO-20 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of RENAU.UNSP.ARD 1/5 EO-20 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Power Finance Corporation Limited
NSE:PFC
-0.052x
Inspur Electronic Info Industr
SHE:000977
-0.327x
SS&C Technologies Holdings Inc
NASDAQ:SSNC
0.094x
Hyundai Rotem Co
KO:064350
-0.010x
Capgemini SE
PA:CAP
0.183x
Beiersdorf Aktiengesellschaft
F:BEIA
0.019x
Sichuan Tianqi Lithium Industries Inc
SHE:002466
0.008x
F5 Networks Inc
NASDAQ:FFIV
0.045x

Annual Cash Flow Conversion Efficiency for RENAU.UNSP.ARD 1/5 EO-20 (2022–2025)

The table below shows the annual cash flow conversion efficiency of RENAU.UNSP.ARD 1/5 EO-20 from 2022 to 2025. For the full company profile with market capitalisation and key ratios, see RENAU.UNSP.ARD 1/5 EO-20 market cap and net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €4.13 Billion
≈ $4.82 Billion
€692.20 Million
≈ $809.25 Million
0.168x -17.18%
2024-12-31 €4.02 Billion
≈ $4.70 Billion
€815.10 Million
≈ $952.94 Million
0.203x -27.43%
2023-12-31 €2.67 Billion
≈ $3.13 Billion
€746.40 Million
≈ $872.62 Million
0.279x +14.62%
2022-12-31 €2.51 Billion
≈ $2.94 Billion
€612.30 Million
≈ $715.84 Million
0.244x --

About RENAU.UNSP.ARD 1/5 EO-20

F:56S0 Germany Medical Instruments & Supplies
Market Cap
$18.08 Billion
€15.47 Billion EUR
Market Cap Rank
#1516 Global
#336 in Germany
Share Price
€15.90
Change (1 day)
-2.45%
52-Week Range
€14.60 - €21.80
All Time High
€35.31
About

Sartorius Stedim Biotech S.A. engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide. The company offers various products, such as cell lines; cell culture media; bioreactors; reagents; advanced therapies; and a range of products for separation, purification, and concentration processes, as well as products and systems for storage and transp… Read more